Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2026-05-08 @ 5:35 AM
Study NCT ID:
NCT03288493
Status:
TERMINATED
Last Update Posted:
2024-03-28
First Post:
2017-09-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)
Sponsor:
Organization:
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Time Perspective List:
Who Masked List: